White House Drug Policy Director to Hold Media Briefing to Address Emergence of Synthetic Drugs
Director Kerlikowske, The Partnership at Drugfree.org to Urge Increased Vigilance Among Parents
(Washington, D.C.) – Gil Kerlikowske, Director of National Drug Control Policy (ONDCP) and President Obama’s top drug policy advisor, will hold a pen and pad media briefing on Thursday, February 16th to discuss the emergence of synthetic drugs. The briefing will take place immediately following a working session co-hosted by ONDCP and The Partnership at Drugfree.org to share data and discuss the public and private sector response to the threat. He will be joined by Steve Pasierb, President and CEO of The Partnership at Drugfree.org, who will share resources and discuss actions parents and adult influencers can take to protect young people from negative consequences.
Often marketed as legal substances, synthetic drugs are sometimes labeled as “herbal incense” or “bath salts” and sold in small pouches or packets over the Internet, in tobacco and smoke shops, drug paraphernalia shops, gas stations, and convenience stores. In December, the National Institute on Drug Abuse released new information indicating that one in nine high school seniors had used “Spice” or “K2” over the past year, making synthetic marijuana the second most frequently used illicit drug, after marijuana, among high school seniors. Poison Control Centers operating across the Nation have also reported sharp increases in the number of calls relating to synthetic drugs.
Who: Gil Kerlikowske, Director of National Drug Control Policy, White House Office of National Drug Control Policy (ONDCP) Steve Pasierb, President and CEO of The Partnership at Drugfree.org
Deborah A. Carr, Executive Director of American Association of Poison Control Centers
Amy Stillwell, Kentucky resident who nearly lost her daughter after use of synthetic marijuana
What: Pen and Pad Media BriefingNews media must RSVP to [email protected] (Call-in number can be provided upon request.)
When: Thursday, February 16th11:00 a.m. EST (media must arrive no later than 10:45am for security processing) Where:
Office of National Drug Control Policy Office of National Drug Control Policy
750 17th Street NW
Washington, DC 20006
For more information about the Office of National Drug Control Policy, visit:
http://www.WhiteHouse.gov/
ONDCP ###
Tags: White House Drug Policy Director to Hold Media Briefing to Address Emergence of Synthetic Drugs




